The efficacy and safety of combination glycoprotein IIbIIIa inhibitors and reduced-dose thrombolytic therapy–facilitated percutaneous coronary intervention for ST-elevation myocardial infarction: A meta-analysis of randomized clinical trials
- 30 April 2007
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 153 (4), 579-586
- https://doi.org/10.1016/j.ahj.2006.12.024
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Regionalization of ST-Segment Elevation Acute Coronary Syndromes Care: Putting a National Policy in Proper PerspectiveJournal of the American College of Cardiology, 2006
- Driving Times and Distances to Hospitals With Percutaneous Coronary Intervention in the United StatesCirculation, 2006
- Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trialThe Lancet, 2006
- Outcome in Patients Transferred for Percutaneous Coronary Intervention (A National Registry of Myocardial Infarction 2/3/4 Analysis)The American Journal of Cardiology, 2005
- A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarctionJournal of the American College of Cardiology, 2003
- Synergistic treatment of ST-segmentelevation myocardial infarction with pharmacoinvasive recanalizationJournal of the American College of Cardiology, 2003
- Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trialsThe Lancet, 2003
- Randomized, Placebo-Controlled Trial of Platelet Glycoprotein IIb/IIIa Blockade With Primary Angioplasty for Acute Myocardial InfarctionCirculation, 1998
- Extended Mortality Benefit of Early Postinfarction ReperfusionCirculation, 1998
- Link Between the Angiographic Substudy and Mortality Outcomes in a Large Randomized Trial of Myocardial ReperfusionCirculation, 1995